A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom
Por:
de Fougerolles, T, Puig-Barbera, J, Kassianos, G, Vanhems, P, Schelling, J, Crepey, P, de Lejarazu, R, Ansaldi, F, Fruhwein, M, Galli, C, Mosnier, A, Pariani, E, Rasuli, A, Vitoux, O, Watkins, J, Weinke, T and Bricout, H
Publicada:
1 may 2022
Ahead of Print:
1 dic 2021
Resumen:
Background In response to the coronavirus disease (COVID-19) outbreak that unfolded across Europe in 2020, the World Health Organisation (WHO) called for repurposing existing influenza surveillance systems to monitor COVID-19. This analysis aimed to compare descriptively the extent to which influenza surveillance systems were adapted and enhanced and how COVID-19 surveillance could ultimately benefit or disrupt routine influenza surveillance. Methods We used a previously developed framework in France, Germany, Italy, Spain and the United Kingdom to describe COVID-19 surveillance and its impact on influenza surveillance. The framework divides surveillance systems into seven subsystems and 20 comparable outcomes of interest and uses five evaluation criteria based on WHO guidance. Information on influenza and COVID-19 surveillance systems were collected from publicly available resources shared by European and national public health agencies. Results Overall, non-medically attended, virological, primary care and mortality surveillance were adapted in most countries to monitor COVID-19, although community, outbreak and hospital surveillance were reinforced in all countries. Data granularity improved, with more detailed demographic and medical information recorded. A shift to systematic notification for cases and deaths enhanced both geographic and population representativeness, although the sampling strategy benefited from the roll out of widespread molecular testing. Data communication was greatly enhanced, contributing to improved public awareness. Conclusions Well-established influenza surveillance systems are a key component of pandemic preparedness, and their upgrade allowed European countries to respond to the COVID-19 pandemic. However, uncertainties remain on how both influenza and COVID-19 surveillance can be jointly and durably implemented.
Filiaciones:
de Fougerolles, T:
CVA, Healthcare Practice, Paris, France
:
Fisabio, Vaccines Res, Valencia, Spain
Kassianos, G:
Royal Coll Gen Practitioners, London, England
British Global & Travel Hlth Assoc, London, England
Vanhems, P:
Lyon Univ Hosp, INSERM, Publ Hlth Epidemiol & Evolutionary Ecol Infect Di, Dept Hyg & Epidemiol,U1111,UCBL, Lyon, France
Ctr Int Rech Infectiol CIRI, Lyon, France
Schelling, J:
Ludwig Maximilians Univ Munchen, Med Fac, Munich, Germany
Crepey, P:
Univ Rennes, Sch Adv Studies Publ Hlth, Rennes, France
de Lejarazu, R:
Univ Valladolid, Valladolid NIC, Valladolid, Spain
Ansaldi, F:
Univ Genoa, Dept Hlth Sci, Genoa, Italy
Fruhwein, M:
Practise Gen Med Travel Med & Trop Dis, Dr Fruehwein & Partners, Munich, Germany
Galli, C:
Univ Milan, Dept Biomed Sci Hlth, Milan, Italy
Mosnier, A:
Reseau GROG, Open Rome, Paris, France
Pariani, E:
Univ Milan, Dept Biomed Sci Hlth, Milan, Italy
Rasuli, A:
Sanofi Pasteur, Med Dept, Lyon, France
Vitoux, O:
CVA, Healthcare Practice, Paris, France
Watkins, J:
Cardiff Univ, Sch Med, Div Populat Med, Cardiff, Wales
Weinke, T:
Klinikum Ernst Bergmann, Med Klin, Gastroenterol, Infektiol,Pneumol, Potsdam, Germany
Bricout, H:
Sanofi Pasteur, Med Dept, Lyon, France
gold, Green Accepted, Green Published, Green Submitted
|